187 related articles for article (PubMed ID: 35743189)
21. Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
Smelov V; Perekalina T; Artemenko N; Smelova N; Ukleeva G; Gorelov A
Andrologia; 2005 Jun; 37(2-3):61-4. PubMed ID: 16026425
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R
J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
[TBL] [Abstract][Full Text] [Related]
24. Chlamydia trachomatis infections: screening, diagnosis, and management.
Mishori R; McClaskey EL; WinklerPrins VJ
Am Fam Physician; 2012 Dec; 86(12):1127-32. PubMed ID: 23316985
[TBL] [Abstract][Full Text] [Related]
25. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Miyashita N; Matsumoto A; Matsushima T
Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Chlamydia trachomatis genital infection.
Toomey KE; Barnes RC
Rev Infect Dis; 1990; 12 Suppl 6():S645-55. PubMed ID: 2201076
[TBL] [Abstract][Full Text] [Related]
28. [Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections].
Noguchi Y
Nihon Rinsho; 2009 Jan; 67(1):173-6. PubMed ID: 19177769
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
[TBL] [Abstract][Full Text] [Related]
30.
Seleem MA; Wood NA; Brinkworth AJ; Manam S; Carabeo RA; Murthy AK; Ouellette SP; Conda-Sheridan M
ACS Infect Dis; 2022 Jan; 8(1):227-241. PubMed ID: 34935346
[No Abstract] [Full Text] [Related]
31. In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.
Nakata K; Maeda H; Fujii A; Arakawa S; Umezu K; Kamidono S
Antimicrob Agents Chemother; 1992 Jan; 36(1):188-90. PubMed ID: 1317145
[TBL] [Abstract][Full Text] [Related]
32.
Corich L; Campisciano G; Zanotta N; Monasta L; Petix V; Favero B; Colli C; De Seta F; Comar M
Future Microbiol; 2019 May; 14():653-660. PubMed ID: 31137965
[No Abstract] [Full Text] [Related]
33. The role of Chlamydia trachomatis and Neisseria gonorrhoeae in the aetiology of ectopic pregnancy in Gabon.
Ville Y; Leruez M; Glowaczower E; Robertson JN; Ward ME
Br J Obstet Gynaecol; 1991 Dec; 98(12):1260-6. PubMed ID: 1777459
[TBL] [Abstract][Full Text] [Related]
34. Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis.
Hakala E; Hanski L; Uvell H; Yrjönen T; Vuorela H; Elofsson M; Vuorela PM
J Antibiot (Tokyo); 2015 Oct; 68(10):609-14. PubMed ID: 25944533
[TBL] [Abstract][Full Text] [Related]
35. Impact of antiseptics on Chlamydia trachomatis growth.
Párducz L; Eszik I; Wagner G; Burián K; Endrész V; Virok DP
Lett Appl Microbiol; 2016 Oct; 63(4):260-7. PubMed ID: 27472980
[TBL] [Abstract][Full Text] [Related]
36. [Chlamydia: diagnostic and treatment].
Jaton K; Greub G
Rev Med Suisse; 2005 Mar; 1(13):895-8, 901-3. PubMed ID: 15895932
[TBL] [Abstract][Full Text] [Related]
37. Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.
Shima K; Szaszák M; Solbach W; Gieffers J; Rupp J
Antimicrob Agents Chemother; 2011 May; 55(5):2319-24. PubMed ID: 21321137
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
[TBL] [Abstract][Full Text] [Related]
39. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
Deguchi T; Hatazaki K; Ito S; Kondo H; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M
J Infect Chemother; 2018 Aug; 24(8):610-614. PubMed ID: 29627327
[TBL] [Abstract][Full Text] [Related]
40. Rectal Chlamydia trachomatis and Neisseria gonorrhoeae Infections Among Women Reporting Anal Intercourse.
Llata E; Braxton J; Asbel L; Chow J; Jenkins L; Murphy R; Pathela P; Schumacher C; Torrone E
Obstet Gynecol; 2018 Sep; 132(3):692-697. PubMed ID: 30095784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
